ARCHIVES

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

Research Needed To Improve Survival In Adolescents, Young Adults With Cancer

January 26, 2007

Radium 223 Dichloride Reduces Death Risk By 30 Percent in Castration-Resistant Disease

August 30, 2013

CCOP RFA Issued; ‘Chop-Like’ Elements Permitted But Not Required; No ‘Cap’; Consortia Allowed

July 16, 1982

Boundary; Opponents Of CMS Policy Step Up The Fight.

November 9, 2007

CCOPs Payline Set In Low 220s Fr Now; 45 To Be Funded

May 15, 1987

In Brief: Moloney, Manaher, 11 Other NCI Staff Members Retire; Terry Takes Leave From Immunology Jobs

March 7, 1980